| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0006100 | Intron-Exon-Intron | chr10:31644073-31677552 | chr10:31355144-31388623 | 101 nt | 0.3663 |
| hsa_ZEB1_0006200 | Intron-Exon-Intron | chr10:31644073-31677801 | chr10:31355144-31388872 | 128 nt | 0.3672 |
| hsa_ZEB1_0006300 | Intron-Exon-Intron | chr10:31644073-31678589 | chr10:31355144-31389660 | 49 nt | 0.3673 |
| hsa_ZEB1_0006400 | Intron-Exon-Intron | chr10:31644073-31678624 | chr10:31355144-31389695 | 611 nt | 0.3895 |
| hsa_ZEB1_0006500 | Intron-Exon-Intron | chr10:31644073-31680153 | chr10:31355144-31391224 | 68 nt | 0.4265 |
| hsa_ZEB1_0006600 | Intron-Exon-Intron | chr10:31644073-31709678 | chr10:31355144-31420749 | 102 nt | 0.4118 |
| hsa_ZEB1_0006700 | Intron-Exon-Intron | chr10:31644073-31714071 | chr10:31355144-31425142 | 192 nt | 0.4271 |
| hsa_ZEB1_0006900 | Intron-Exon-Intron | chr10:31644073-31771587 | chr10:31355144-31482658 | 51 nt | 0.3333 |
| hsa_ZEB1_0007000 | Intron-Exon-Intron | chr10:31644073-31776320 | chr10:31355144-31487391 | 52 nt | 0.3654 |
| hsa_ZEB1_0007100 | Exon-Exon | chr10:31644073-31784767 | chr10:31355144-31495838 | 63 nt | 0.5397 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].